Loading…
Changshu Ximaide's advanced drug delivery device R&D and manufacturing base opened in Changshu Economic Development Zone on August 6, 2024. The project, with a total investment of CNY 500 million, includes a 30,000-square-meter GMP factory, R&D center, and headquarters, designed to produce 50 million drug delivery devices annually.
| Site | Largest | Latest |
|---|---|---|
| Changshu, China | $69.4M | 2024-08-07 |